Infliximab-induced psoriasis in a patient with crohn′s disease

Infliximab-induced psoriasis in a patient with crohn′s disease

Infliximab is a well-known treatment for inflammatory bowel diseases (IBDs) and psoriasis. Paradoxically, there have been numerous reports of new-onset psoriasis following tumor necrosis factor-α antagonist therapy in patients with IBD. Here, we report a case with Crohn′s disease who developed Infli...

Full description

Bibliographic Details
Main Authors:	Iqbal Bukhari, Nasser Alzoubi, Abdulaziz A Al-Quorain
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2015-01-01
Series:	Saudi Journal of Medicine and Medical Sciences
Subjects:	Biological therapy Crohn′s disease Infliximab psoriasis tumor necrosis factor-alpha inhibitors
Online Access:	http://www.sjmms.net/article.asp?issn=1658-631X;year=2015;volume=3;issue=1;spage=81;epage=83;aulast=Bukhari

Similar Items

Infliximab-induced intertriginous psoriasis in patient with Crohn's desease
by: Federica Mola, et al.
Published: (2011-10-01)

Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
by: Matsumoto S, et al.
Published: (2018-07-01)

Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
by: Subedi S, et al.
Published: (2019-07-01)

ADALIMUMAB INDUCTION AND MAINTAINING REMISSION FOR CROHN’S DISEASE IN PATIENT WHO LOST RESPONSE TO INFLIXIMAB. Case report
by: Ivaylo Vazharov, et al.
Published: (2016-12-01)

HOW IS THE DIET QUALITY OF PATIENTS WITH CROHN’S DISEASE IN CLINICAL REMISSION USING INFLIXIMAB?
by: Melissa Mercadante Santana CRUZ, et al.
Published: (2021-10-01)

Development of Spinal Tuberculosis in an Adolescent With Crohn's Disease After Infliximab Therapy: A Case Report With Literature Review
by: Jae Hoon Jung, et al.
Published: (2022-02-01)

Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
by: You Lim Kim, et al.
Published: (2014-01-01)

Association between infliximab concentrations and clinical response in psoriasis: a prospective cohort study
by: M. Colls-Gonzalez, et al.
Published: (2021-02-01)

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn’s disease
by: J Dretzke, et al.
Published: (2011-02-01)

Early intestinal obstruction after infliximab therapy in Crohn’s disease
by: Mitsuro Chiba, et al.
Published: (2019-08-01)

Successful Treatment of Postoperative Fistula with Infliximab in a Patient with Crohn's Disease
by: Seong Yeon Jeong, et al.
Published: (2014-01-01)

Adenocarcinoma de recto y ano en paciente con enfermedad de Crohn tratado con infliximab Adenocarcinoma of the rectum and anus in a patient with Crohn´s disease treated with infliximab
by: J. Egea Valenzuela, et al.
Published: (2010-08-01)

Infliximab-Induced Aseptic Meningitis during the Treatment of Psoriatic Arthritis
by: Yuki Matsuura-Otsuki, et al.
Published: (2017-05-01)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn’s Disease
by: Luis Eduardo Miani Gomes, et al.
Published: (2019-04-01)

Effectiveness of infliximab biosimilars in the treatment of moderate to severe chronic plaque psoriasis: experience of real-world data from the register of the program “Treatment of moderate and severe forms of plaque psoriasis (B.47)” of the National Health Fund in Poland
by: Witold Owczarek, et al.
Published: (2021-08-01)

Long-Term Clinical Outcomes of Korean Patient With Crohn's Disease Following Early Use of Infliximab
by: Nam Hee Kim, et al.
Published: (2014-10-01)

Fecal Microbiota Transplantation is a Promising Switch Therapy for Patients with Prior Failure of Infliximab in Crohn’s Disease
by: Qianqian Li, et al.
Published: (2021-05-01)

A Case of Severe Panuveitis Associated with Psoriasis Vulgaris Successfully Treated with Infliximab
by: Yuri Sakurai, et al.
Published: (2016-04-01)

Recurrent ruptured abdominal aneurysms in polyarteritis nodosa successfully treated with infliximab
by: Lerkvaleekul B, et al.
Published: (2019-06-01)

Successful treatment of infliximab-induced psoriasiform skin lesions despite biologic therapy intensification in a paediatric patient with Crohn’s disease and primary sclerosing cholangitis
by: Agata Wasilewska, et al.
Published: (2021-07-01)

Cortical Vein Thrombosis after Infliximab Treatment for Crohn’s Disease
by: Saeed Razmeh, et al.
Published: (2021-03-01)

Infliximab tolerance in patients with rheumatoid arthritis in real clinical practice
by: E. S. Aronova, et al.
Published: (2020-02-01)

Delayed Diagnosis of Vulvar Crohn’s Disease in a Patient with No Gastrointestinal Symptoms
by: Leah Ellis Wells, et al.
Published: (2018-11-01)

Tratamiento biológico en psoriasis: Revisión bibliográfica Biologic therapy of psoriasis: Literature review
by: MS Lorenzetti, et al.
Published: (2012-06-01)

Loss of Response to Long-Term Infliximab Therapy in Children with Crohn’s Disease
by: George Alex, et al.
Published: (2013-10-01)

Trabeculotomy in a Behçet’s Disease Patient One Week after Infliximab Administration
by: Aya Koike, et al.
Published: (2012-04-01)

Biomarkers and Predictive Factors for Treatment Response to Tumor Necrosis Factor-α Inhibitors in Patients with Psoriasis
by: Teppei Hagino, et al.
Published: (2023-01-01)

Association between serum tumor necrosis factor-alpha level and the efficacy of infliximab for refractory pouchitis after restorative proctocolectomy in patients with ulcerative colitis
by: Motoi Uchino, et al.
Published: (2017-10-01)

Infliximab
by: İlgen Ertam Sağduyu
Published: (2022-04-01)

The impact of medication belief on adherence to infliximab in patients with Crohn’s disease
by: Shuyan Li, et al.
Published: (2023-08-01)

Anti-NMDAR encephalitis in Crohn’s disease undergoing long-term infliximab treatment: A case report
by: Shin Ju Oh, et al.
Published: (2022-10-01)

Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction—A Prospective Trial
by: Karoline Soares Garcia, et al.
Published: (2023-06-01)

Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab
by: Diana Carvalho, et al.
Published: (2017-09-01)

Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis
by: Laurent Peyrin-Biroulet, et al.
Published: (2022-06-01)

Predictors of response to infliximab in patients with fistulizing Crohn's disease Factores predictivos de respuesta a infliximab en pacientes con enfermedad de Crohn fistulizante
by: M. Luna-Chadid, et al.
Published: (2004-06-01)

Ustekinumab successfully treated a patient with severe psoriasis vulgaris with primary failure to infliximab and secondary failure to adalimumab
by: Chiharu Tateishi,, et al.
Published: (2015-07-01)

Tumor Necrosis Factor’s Pathway in Crohn’s Disease: Potential for Intervention
by: Cristiano Pagnini, et al.
Published: (2021-09-01)

Efficacy of Infliximab for the Treatment of Oral Manifestation of Crohn’s Disease
by: Aibar Aginbay, et al.
Published: (2022-11-01)

Dramatic response to infliximab in refractory neurosarcoidosis
by: Chintamaneni Sreekanth, et al.
Published: (2010-01-01)

Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease
by: Ye Ma, et al.
Published: (2023-03-01)